Anne-Marie Graffin
Chairman chez VALNEVA
Fortune : 3 060 $ au 31/03/2024
Profil
Anne-Marie Graffin is currently the Deputy Chairman-Supervisory Board at Nanobiotix SA since 2014.
She is also currently the Chairman at Valneva SE since 2013.
Additionally, she holds the position of Director at Vétoquinol SA. In 2015, she became the Lead Independent Non-Executive Director at Sartorius Stedim Biotech SA. Prior to her current roles, she was the Managing Director & Manager at Smag Consulting SARL since 2011 and the President & Independent Non-Executive Director at Smag Consulting S.A.S.
since 2011.
In terms of former positions, Ms. Graffin was the Chief Executive Officer at Big Booster Club.
From 1998 to 2010, she served as the Director at MSD Vaccines Ltd.
She also held the position of Director at Sanofi España SA. From 2012 to 2015, she was the Director at Themis Bioscience GmbH.
She served as the Director at Sanofi Pasteur MSD Ltd.
(Ireland) and Sanofi Pasteur MSD SA (Spain).
Additionally, she was the Managing Director at Latham BioPharm Group, Inc. From 2004 to 2008, she held the role of Chief Business Officer at Xcellerex, Inc. She was the Manager-France Products at International Distillers & Vintners Ltd.
from 1984 to 1987.
She also worked as a Brand Manager at Laboratoires URGO SA and later as a Marketing Manager at the same company from 1988 to 1990.
From 1998 to 2011, she served as the Vice President-Business Management at Sanofi Pasteur MSD SA and Sanofi Pasteur MSD SNC.
She was a Brand Manager at Roc SA from 1991 to 1995.
She is currently a Member-Supervisory Board at M2care SAS.
Lastly, she was a Manager at Urgo laboratories from 1988 to 1990.
Ms. Graffin obtained an MBA from ESSEC Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
VALNEVA SE
0,00% | 04/03/2024 | 779 ( 0,00% ) | 3 060 $ | 31/03/2024 |
Postes actifs de Anne-Marie Graffin
| Sociétés | Poste | Début |
|---|---|---|
| NANOBIOTIX | Director/Board Member | 01/01/2014 |
| VALNEVA | Chairman | 20/12/2023 |
| SARTORIUS STEDIM BIOTECH | Director/Board Member | 07/04/2015 |
| VETOQUINOL SA | Director/Board Member | - |
| Smag Consulting SARL | Chief Executive Officer | 01/09/2011 |
Anciens postes connus de Anne-Marie Graffin
| Sociétés | Poste | Fin |
|---|---|---|
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Director/Board Member | 01/01/2015 |
Sanofi Pasteur MSD SNC
 Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD SNC is engaged in the wholesale of pharmaceutical products. The company was founded on August 16, 1993 and is headquartered in Lyon, France. | Corporate Officer/Principal | 01/01/2011 |
| Sanofi Pasteur MSD SA | Corporate Officer/Principal | 01/01/2011 |
MSD Vaccines Ltd.
 MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Director/Board Member | 01/01/2010 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Anne-Marie Graffin
| ESSEC Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| VETOQUINOL SA | Health Technology |
| SARTORIUS STEDIM BIOTECH | Health Technology |
| NANOBIOTIX | Health Technology |
| VALNEVA | Health Technology |
| Entreprise privées | 15 |
|---|---|
Xcellerex, Inc.
 Xcellerex, Inc. Pharmaceuticals: MajorHealth Technology Xcellerex, Inc. manufactures and provides equipment to produce bio-molecules. Its products and services include FlexFactory, a bioprocess manufacturing platform that handles the production of bio-products, such as vaccines, yeast and insulins. The company was founded by Parrish M. Galliher in 2002 and was headquartered in Marlborough, MA. | Health Technology |
International Distillers & Vintners Ltd.
 International Distillers & Vintners Ltd. Food DistributorsDistribution Services International Distillers & Vintners Ltd. is a British company that imports and distributes specialty beers and spirits worldwide, including the Americas. The joint venture company's mission is to provide nationwide service to their customers while committing to long term brand building activities. The company prides itself on its broad range of high-quality products, including wines, spirits, and beer from countries around the world. The company is the exclusive importer and distributor of a variety of products. | Distribution Services |
Laboratoires URGO SA
 Laboratoires URGO SA Medical SpecialtiesHealth Technology Laboratoires URGO SA provides surgical dressings and adhesive plasters. Its products include tapes, traditional plasters, burn range, podology, and filmogel technology. The company was founded in 1958 and is headquartered in Chenôve, France. | Health Technology |
MSD Vaccines Ltd.
MSD Vaccines Ltd. Pharmaceuticals: OtherHealth Technology MSD Vaccines Ltd. manufactures and supplies vaccines. Its main way of achieving this goal is to develop and make available innovative vaccines against a wide spectrum of diseases. It also dedicated to increasing the understanding of the value of vaccines and vaccination by providing relevant and accurate information on their quality, safety and efficacy. The company was founded in 1975 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
| Sanofi España SA | |
| Sanofi Pasteur MSD SA | |
Sanofi Pasteur MSD SNC
Sanofi Pasteur MSD SNC Pharmaceuticals: MajorHealth Technology Sanofi Pasteur MSD SNC is engaged in the wholesale of pharmaceutical products. The company was founded on August 16, 1993 and is headquartered in Lyon, France. | Health Technology |
Themis Bioscience GmbH
Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Health Technology |
Sanofi Pasteur MSD Ltd. (Ireland)
 Sanofi Pasteur MSD Ltd. (Ireland) BiotechnologyHealth Technology Part of Merck & Co., Inc., Sanofi Pasteur MSD Ltd. is a private company based in Dublin, Ireland. The Irish company develops and produces vaccines. | Health Technology |
Sanofi Pasteur MSD SA (Spain)
 Sanofi Pasteur MSD SA (Spain) Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Sanofi Pasteur MSD SA is a private company based in Madrid, Spain. The Spanish company develops vaccines. | Health Technology |
| Smag Consulting SARL | |
Roc SA
 Roc SA Real Estate DevelopmentFinance Roc SA provides housing development services. | Finance |
Latham BioPharm Group, Inc.
 Latham BioPharm Group, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sia Partners SASU, Latham BioPharm Group, Inc. is a leading life science consulting private company that works with pharmaceutical, biotech, CROs, academia, and medical device/diagnostic companies to solve complex business, regulatory, and product development challenges. The company was founded in 1996 by Peter Latham and is based in Elkridge, MD. LBG's core services include comprehensive functional expertise in vaccines, therapeutics, cell & gene therapy, medical devices, and diagnostics. The company provides technical expertise, quality oversight, strategic analysis, and knowledge management necessary to successfully navigate the complex roadmap of life sciences product development. LBG has helped clients identify, evaluate, fund, manage, and monetize opportunities, generating over $1 billion in non-dilutive funding and over $100 million in licensing fees and investments. Latham BioPharm Group was acquired by Sia Partners SASU on October 14, 2022. | Commercial Services |
M2care SAS
 M2care SAS Miscellaneous Commercial ServicesCommercial Services M2care SAS is a French healthcare company founded in 2017. The company is based in Lyon, France. M2care is a team of passionate entrepreneurs who invest in human and financial value to co-found, co-operate, and co-develop innovative projects in the healthcare sector until they reach the patient. | Commercial Services |
| Big Booster Club |
